Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-10-17
2006-10-17
Aulakh, Charanjit S. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S143000, C546S146000, C546S139000, C514S307000
Reexamination Certificate
active
07122559
ABSTRACT:
Compounds having the formula (I),or a stereoisomer or pharmaceutically-acceptable salt, or hydrate thereof, are useful as factor VIIa inhibitors, wherein X is —NR6S(O)pR16; W is hydrogen or —(CR7R8)q—W1; W1is hydrogen or a bond with R6; Z is a5-membered heteroaryl group, a five to six membered heterocyclo or cycloalkyl group, a9to10membered bicyclic aryl or heteroaryl, or a six membered aryl or heteroaryl, and R1, R2, R3, R6, R7, and R16are as defined in the specification.
REFERENCES:
patent: 6140353 (2000-10-01), Ackermann et al.
patent: 6194409 (2001-02-01), van Boeckel et al.
patent: 6242644 (2001-06-01), Ackermann et al.
patent: 6335324 (2002-01-01), Bisacchi et al.
patent: 6358960 (2002-03-01), Senokuchi et al.
patent: 6472393 (2002-10-01), Aliagas-Martin et al.
patent: 6642252 (2003-11-01), Bisacchi et al.
patent: 6699994 (2004-03-01), Babu et al.
patent: WO 96/20689 (1996-07-01), None
patent: WO 97/10214 (1997-03-01), None
patent: WO 01/44172 (2001-06-01), None
patent: WO 01/90051 (2001-11-01), None
patent: WO 02/09688 (2002-02-01), None
patent: WO 2002/034711 (2002-05-01), None
patent: WO 2003013531 (2003-02-01), None
patent: WO 03/66588 (2003-08-01), None
patent: WO 2003/084533 (2003-10-01), None
patent: WO2004/072102 (2004-08-01), None
U.S. Appl. No. 10/775,443, filed Feb. 10, 2004, Bisacchi et al.
Stedman's Medical Dictionary, 27thEdition Illustrated in Color, Lippincott Williams & Wilkins, 1999, pp. 1711, 1831, 1832.
Dorland's Illustrated Medical Dictionary, 29thEdition, W.B. Saunders Company, 2000, pp. 1836, 1837.
Robbins Pathologic Basis of Disease, Sixth Edition, W. B. Saunders Company, 1999, pp. 113-138.
Hurst's The Heart, 10thEdition, 2001, pp. 1373-1384.
Harrison's Principles of Internal Medicine, 14thEdition, vol. 2, 1998, pp. 2325-2348.
Bisacchi Gregory S.
Glunz Peter W.
Holubec Alexandra A.
Morton George C.
Priestley E. Scott
Aulakh Charanjit S.
Bristol--Myers Squibb Company
Sun Jing G.
LandOfFree
Phenylglycine derivatives useful as serine protease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phenylglycine derivatives useful as serine protease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phenylglycine derivatives useful as serine protease inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3718783